Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 31.
doi: 10.1111/bjh.70132. Online ahead of print.

Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas

Lydia Montes  1 , Sylvain Choquet  2 , Madalina Uzunov  2 , Véronique Morel  3 , Marine Baron  2 , Damien Roos-Weil  2 , Magalie Joris  1 , Caroline Delette  1 , Delphine Lebon  1 , Nabih Azar  2 , Carole Metz  4 , Lucia Nichelli  5 , Magali Le Garff-Tavernier  6 , Clémentine Boccon-Gibod  2 , Claire Lacan  2 , Laetitia Souchet  2 , Khê Hoang-Xuan  7 , Carole Soussain  8 , Inès Boussen  2 , Caroline Houillier  7
Affiliations

Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas

Lydia Montes et al. Br J Haematol. .
No abstract available

Keywords: CART cells; autologous stem cell transplantation; chemotherapy; lymphoma.

PubMed Disclaimer

References

REFERENCES

    1. Houillier C, Taillandier L, Dureau S, Lamy T, Laadhari M, Chinot O, et al. Radiotherapy or autologous stem‐cell transplantation for primary CNS lymphoma in patients 60 years of age and younger: results of the Intergroup ANOCEF‐GOELAMS Randomized Phase II PRECIS Study. J Clin Oncol. 2019;37(10):82333.
    1. Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosée P, et al. Whole‐brain radiotherapy or autologous stem‐cell transplantation as consolidation strategies after high‐dose methotrexate‐based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group‐32 phase 2 trial. Lancet Haematol. 2017;4(11):e51023.
    1. Schenone L, Houillier C, Tanguy ML, Choquet S, Agbetiafa K, Ghesquières H, et al. Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network. Bone Marrow Transplant. 2022;57(6):96674.
    1. Houillier C, Soussain C, Ghesquières H, Soubeyran P, Chinot O, Taillandier L, et al. Management and outcome of primary CNS lymphoma in the modern era: an LOC network study. Neurology. 2020;94(10):e1027–e1039. https://doi.org/10.1212/WNL.0000000000008900
    1. Locke FL, Miklos DB, Jacobson CA, Perales MA, Kersten MJ, Oluwole OO, et al. Axicabtagene ciloleucel as second‐line therapy for large B‐cell lymphoma. N Engl J Med. 2022;386(7):64054.

Grants and funding